Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion type Assertion NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_head.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion description "[Loss of annexin II heavy chain appears to be specific for prostate cancer since overexpression of annexin II is observed in a majority of human cancers, including pancreatic cancer, breast cancer and brain tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_provenance.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion evidence source_evidence_literature NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_provenance.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion SIO_000772 12962548 NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_provenance.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion wasDerivedFrom befree-2016 NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_provenance.
- NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_assertion wasGeneratedBy ECO_0000203 NP408081.RAGTHeSFe1RyxGveLEsmV3Vqotb4pQHhmuAhkWhTx9SL8130_provenance.